HWSCX
Price
$69.81
Change
+$0.80 (+1.16%)
Updated
Aug 4 closing price
Net Assets
869.84M
SSGSX
Price
$54.35
Change
-$0.24 (-0.44%)
Updated
Aug 5 closing price
Net Assets
4.57B
Interact to see
Advertisement

HWSCX vs SSGSX

HWSCX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
HWSCX vs. SSGSX commentary
Aug 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HWSCX is a Buy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.57B vs. HWSCX (870M). SSGSX pays higher dividends than HWSCX: SSGSX (0.52) vs HWSCX (0.07). HWSCX was incepted earlier than SSGSX: HWSCX (25 years) vs SSGSX (27 years). HWSCX (1.96) is less costly to investors than SSGSX (1.23). SSGSX is a more actively managed with annual turnover of: 50.00 vs. HWSCX (41.00). HWSCX (2500) and SSGSX (2500) have matching initial minimum investment requirements. HWSCX annual gain was more profitable for investors over the last year : 30.44 vs. SSGSX (24.15). HWSCX return over 5 years is better than : 33.01 vs. SSGSX (0.90).
HWSCXSSGSXHWSCX / SSGSX
Total Expense Ratio1.961.23159%
Annual Report Gross Expense Ratio1.961.23159%
Fund Existence25 years27 years-
Gain YTD25.93122.153117%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets870M4.57B19%
Annual Yield % from dividends0.070.5213%
Returns for 1 year30.4424.15126%
Returns for 3 years24.8313.05190%
Returns for 5 years33.010.903,650%
Returns for 10 years64.8842.89151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WST351.022.26
+0.65%
West Pharmaceutical Services
TCBX44.270.15
+0.34%
Third Coast Bancshares
TLYS4.18-0.07
-1.65%
Tilly's
PMCB0.59-0.01
-1.83%
PharmaCyte Biotech
RCUS27.70-1.10
-3.82%
Arcus Biosciences